Abstract:Objective To identify key factors influencing the therapeutic efficacy of the ketogenic diet (KD) for children with drug‐resistant epilepsy and elucidate their interconnected relationships to optimize clinical practice. Methods Participants were selected from children receiving KD treatment at West Second University Hospital of Sichuan University from September 2015 to October 2023. Clinical factors pre‐KD and post‐KD (at the third month) were analyzed systematically using an analytical framework. Descriptive analyses, univariate analyses, and multivariate regression analyses were performed for the entire cohort and subgroups of genetic and non‐genetic (i.e., structural and unknown) etiologies. Thereby, the most significant predictors were identified for each relevant dependent variable. Path analysis diagrams were used for visual representation. Results Of 156 patients, genetic etiology was prevalent (38.5%). In the genetic subgroup, channelopathies predicted lower baseline seizure frequency and increased chance of seizure freedom with KD. Frequent seizures and complex history of anti‐seizure medications (ASMs) predicted severe baseline psychomotor abnormalities. Younger age at KD initiation benefited psychomotor improvement. In the non‐genetic subgroup, lower baseline seizure frequency increased the likelihood of seizure freedom post‐KD. Concurrent use of multiple ASMs helped achieve ≥50% seizure reduction. Boys were more likely to experience psychomotor improvement. A significant correlation was found between ≥50% seizure reduction and psychomotor improvement in both subgroups. Delayed KD initiation (longer epilepsy duration at KD start) was related to a greater number of ASMs used, infrequent seizures, and older age at epilepsy onset. In addition, patients with channelopathies had delayed initiation of KD. Significance Children with genetic epilepsy display more pronounced characteristics of epileptic encephalopathy. Early KD intervention is crucial for channelopathies, notably SCN1A variants. For other drug‐resistant epilepsy cases, KD alongside diverse ASMs may improve seizure control and developmental outcomes. However, the patient population benefiting most from early KD tends to start the treatment later, urging a re‐evaluation of KD decision‐making paradigms.

Three and Six Months of Ketogenic Diet for Intractable Childhood Epilepsy: A Systematic Review and Meta-Analysis.

Therapeutic Success of the Ketogenic Diet As A Treatment Option for Epilepsy: A Meta-Analysis

Six-month efficacy of the Ketogenic diet is predicted after 3 months and is unrelated to clinical variables

Prospective Study on Ketogenic Diet on Refractory Epilepsy in Children

Efficacy, Retention Rate, and Influencing Factors of Ketogenic Diet Therapy in Children with Refractory Epilepsy: A Retrospective Study

Therapeutic Effects of the Ketogenic Diet in Children with Lennox-Gastaut Syndrome

Long-term Effective Rate,retention Rate and Tolerability of the Ketogenic Diet in Paediatrics Drug-Resistant Epilepsies

Efficacy and safety of a ketogenic diet in children with drug-resistant epilepsy

Optimized mid-long term management of ketogenic diet in children with refractory epilepsy

Analysis of the efficacy and safety of inpatient and outpatient initiation of KD for the treatment of pediatric refractory epilepsy using generalized estimating equations

Prospective study of the efficacy of a ketogenic diet in 20 patients with Dravet syndrome

Long-term effectiveness and seizure recurrence risk factors of ketogenic diet for pediatric refractory epilepsy: Experience from a tertiary care center in China

Ketogenic Diet for Treatment of Intractable Epilepsy in Adults: A Meta‐analysis of Observational Studies

Optimizing ketogenic diet therapy for childhood epilepsy: Identifying key factors for seizure control and psychomotor enhancement

Clinical Analysis of Ketogenic Diet for 25 Children with Infantile Spasms

A multicenter retrospective cohort study of ketogenic diet therapy in 481 children with infantile spasms

Safety and Effectiveness of the Prolonged Treatment of Children with a Ketogenic Diet

Ketogenic diet for epilepsy: an overview of systematic review and meta-analysis

Prospective control study of efficacy and influencing factors of a ketogenic diet on refractory epilepsy in children

The Efficacy of Ketogenic Diet in 60 Chinese Patients with Dravet Syndrome

Ketogenic diet therapy in infants less than two years of age for medically refractory epilepsy